We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Apotex Is Warned Again for Ongoing GMP Issues
The item has been added to your shopping cart.
Apotex Is Warned Again for Ongoing GMP Issues
May 3, 2010
Apotex’s Toronto facility has received an FDA warning letter citing several GMP deficiencies for finished products, including the alleged use of
contaminated ingredients.